Gyrodyne, LLC (GYRO)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Gyrodyne, LLC (GYRO) trades at $6.13 with AI Score 45/100 (Grade C). Gyrodyne, LLC is a real estate company that owns, leases, and manages commercial properties. Market cap: $13.47M, Sector: Real estate.
Price live · AI analysis from May 10, 2026Analyst Coverage for GYRO: GYRO does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates GYRO against Real Estate peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
GYRO: the 1 perspectives are evenly split.
How is this calculated? →Gyrodyne, LLC (GYRO) Real Estate Portfolio & Strategy
Gyrodyne, LLC, a real estate firm with a $13.47M market cap, specializes in owning, leasing, and managing commercial properties. Distinguished by its service-oriented philosophy, the company has evolved from a regional Long Island player to a diversified East Coast presence, particularly in the medical office sector.
What Is the Investment Thesis for GYRO?
Gyrodyne, LLC presents a focused investment opportunity within the commercial real estate sector, specifically targeting medical office properties on the East Coast. With a market capitalization of $13.47M and a beta of 0.53, the company exhibits lower volatility compared to the broader market. Key value drivers include the company's service-oriented approach to property management, which fosters tenant loyalty and stable occupancy rates. Growth catalysts include the increasing demand for medical office space driven by an aging population and advancements in healthcare technology. However, potential risks include fluctuations in interest rates and economic downturns that could impact property values and rental income. The absence of dividend payments may deter some investors, but the company's focus on growth and strategic property management could yield long-term capital appreciation.
Based on FMP financials and quantitative analysis
GYRO Key Highlights
- Gyrodyne, LLC focuses on medical office properties, capitalizing on the growing healthcare sector.
- The company's service-oriented approach fosters strong tenant relationships and stable occupancy rates.
- Gyrodyne has expanded from a regional Long Island player to a diversified East Coast presence.
- With a market cap of $13.47M and a beta of 0.53, Gyrodyne exhibits lower volatility compared to the broader market.
- Gyrodyne's lean operational structure, with only 6 employees, allows for efficient management and cost control.
Who Are GYRO's Competitors?
GYRO is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| OMH Ohmyhome Limited operates an online property platform in Singapore, Malaysia, and the Philippines, offering real estate brokerage services. The company | $0.50 | -0.82% | $11.48M | 68 |
| CRSS Crossroads Impact Corp. | $7.00 | +0.00% | $74.33M | 66 |
| SDWHF Soundwill Holdings Limited | $0.87 | -0.01% | $246.92M | 64 |
| NTPIF Nam Tai Property Inc. | $4.75 | +0.00% | $289.75M | 64 |
| WRFRF Wharf Real Estate Investment Company Limited | $2.70 | +0.00% | $8.20B | 51 |
| WE WeWork Inc. | $0.84 | -24.73% | $44.08M | 51 |
| AZLCZ Aztec Land and Cattle Company, Limited | $2442.00 | +0.00% | $222.22M | 51 |
| ASPZ Asia Properties, Inc. | $0.04 | +0.00% | $25.85M | 51 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GYRO's Key Strengths?
- Service-oriented approach to property management.
- Focus on medical office properties.
- Strategic East Coast presence.
- Lean operational structure.
What Are GYRO's Weaknesses?
- Small market capitalization.
- Limited geographic diversification.
- Dependence on commercial real estate market conditions.
- Small number of employees.
What Could Drive GYRO Stock Higher?
- Potential acquisitions of new medical office properties by Q4 2026.
- Increasing demand for medical office space due to aging population.
- Strategic partnerships with healthcare providers to secure long-term leases.
What Are the Key Risks for GYRO?
- Financial-distress signal — its Altman Z-Score of 0.33 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Fluctuations in interest rates impacting property values and financing costs.
- Economic downturns reducing demand for commercial real estate.
- Competition from larger REITs with greater resources.
- Changes in healthcare regulations affecting tenant occupancy.
What Are the Growth Opportunities for GYRO?
- Expansion into Underserved Markets: Gyrodyne can capitalize on the increasing demand for medical office space in underserved markets along the East Coast. By identifying areas with limited access to healthcare facilities and a growing population, Gyrodyne can develop or acquire properties to meet this demand. This expansion strategy could involve partnering with local healthcare providers to ensure a steady stream of tenants. The market size for medical office space is projected to reach $167.2 billion by 2028, presenting a significant opportunity for Gyrodyne to increase its market share. Timeline: 2026-2028.
- Strategic Acquisitions of Existing Properties: Gyrodyne can pursue strategic acquisitions of existing medical office properties to expand its portfolio and geographic reach. By acquiring well-maintained and strategically located properties, Gyrodyne can quickly increase its revenue and market presence. This acquisition strategy could focus on properties with high occupancy rates and long-term leases, providing a stable income stream. The market for commercial real estate acquisitions is expected to remain active, with opportunities to acquire properties at attractive valuations. Timeline: Ongoing.
- Development of New Medical Office Facilities: Gyrodyne can develop new medical office facilities to meet the evolving needs of healthcare providers. By designing and constructing state-of-the-art facilities with advanced technology and flexible layouts, Gyrodyne can attract high-quality tenants and command premium rental rates. This development strategy could focus on creating specialized facilities for specific medical specialties, such as oncology or cardiology. The demand for new medical office facilities is driven by the increasing complexity of healthcare and the need for modern, efficient spaces. Timeline: 2027-2030.
- Enhancement of Property Management Services: Gyrodyne can enhance its property management services to improve tenant satisfaction and retention. By providing proactive maintenance, responsive customer service, and value-added amenities, Gyrodyne can create a positive tenant experience and reduce turnover. This service-oriented approach can differentiate Gyrodyne from its competitors and attract high-quality tenants. The market for property management services is expected to grow as property owners seek to optimize their operations and maximize their returns. Timeline: Ongoing.
- Leveraging Technology for Operational Efficiency: Gyrodyne can leverage technology to improve its operational efficiency and reduce costs. By implementing advanced property management software, online tenant portals, and automated maintenance systems, Gyrodyne can streamline its operations and improve communication with tenants. This technology-driven approach can free up resources and allow Gyrodyne to focus on strategic growth initiatives. The market for property management technology is rapidly evolving, with new solutions emerging to address the challenges of managing commercial properties. Timeline: 2026-2027.
What Opportunities Does GYRO Have?
- Expansion into underserved markets.
- Strategic acquisitions of existing properties.
- Development of new medical office facilities.
- Enhancement of property management services.
What Threats Does GYRO Face?
- Fluctuations in interest rates.
- Economic downturns impacting property values.
- Increased competition from larger REITs.
- Changes in healthcare regulations.
What Are GYRO's Competitive Advantages?
- Service-oriented approach fosters tenant loyalty.
- Focus on medical office properties creates a niche market.
- Strategic East Coast presence provides geographic diversification.
What Does GYRO Do?
Gyrodyne, LLC is a real estate company focused on the ownership, leasing, and management of commercial properties. Founded with a commitment to providing exceptional service, Gyrodyne distinguishes itself through a hands-on, service-oriented approach to property ownership and management. Initially concentrated in Long Island, New York, the company has strategically expanded its footprint to encompass a diversified portfolio of properties across the East Coast. This expansion reflects a deliberate effort to capitalize on emerging market opportunities and diversify its revenue streams. Gyrodyne's portfolio includes a variety of commercial properties, with a particular emphasis on medical office buildings. This focus allows Gyrodyne to cater to the specific needs of healthcare providers, offering specialized facilities and management services tailored to the medical industry. The company's commitment to service, combined with its strategic focus on medical office properties, positions it as a key player in the East Coast commercial real estate market. Gyrodyne manages its properties with a lean team of 6 employees, led by CEO Gary Jay Fitlin.
What Products and Services Does GYRO Offer?
- Owns a portfolio of commercial properties.
- Leases commercial spaces to tenants.
- Manages its properties, including maintenance and tenant relations.
- Focuses on medical office properties.
- Provides service-oriented property management.
- Expands its presence on the East Coast.
How Does GYRO Make Money?
- Generates revenue through rental income from commercial properties.
- Increases property value through strategic management and improvements.
- Expands portfolio through acquisitions and development.
What Industry Does GYRO Operate In?
Gyrodyne, LLC operates within the real estate services industry, which is influenced by macroeconomic factors such as interest rates, employment rates, and population growth. The demand for commercial real estate, particularly medical office space, is driven by the aging population and the increasing need for healthcare services. The competitive landscape includes larger real estate investment trusts (REITs) and smaller regional players. Gyrodyne differentiates itself through its service-oriented approach and focus on medical office properties, positioning it to capture a niche market within the broader real estate sector. The industry is expected to see continued growth in demand for specialized medical facilities, creating opportunities for companies like Gyrodyne.
Who Are GYRO's Key Customers?
- Healthcare providers seeking medical office space.
- Commercial tenants requiring office or retail space.
- Investors seeking stable income from real estate.
ROE 0%Key Financial Metrics
Return on equity for Gyrodyne, LLC stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.25 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.
How Gyrodyne, LLC Is Valued
Gyrodyne, LLC carries a market capitalization of $13.47M, placing it in the micro-cap category. Relative to its peer group, GYRO's quantitative score of 45/100 is below the peer average of 63/100.
F-Score 1/9Financial Health
Gyrodyne, LLC's Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 0.33 places it in the distress zone, a signal of elevated financial risk.
GYRO Financials
Bull Case vs Bear Case
Bull Case
- Gyrodyne's recent insider buying suggests those in the know see value, a classic bullish signal.
- The community buzz around Gyrodyne points to growing optimism, indicating positive market perception.
- Recent developments suggest Gyrodyne might be gaining traction in its sector; think of it like a smaller Palantir gaining government contracts.
- Bullish community members highlight Gyrodyne's potential for long-term growth, echoing early Tesla believers.
Bear Case
- Limited information available makes it hard to assess Gyrodyne's true potential, a red flag for many.
- Bearish sentiment in the community focuses on Gyrodyne's lack of visibility, similar to a small biotech facing big pharma competition.
- Recent market perception casts doubt on Gyrodyne's ability to scale effectively, a concern reminiscent of early stage startups.
- Insider activity, while showing buys, is not overwhelmingly bullish, suggesting caution among some insiders.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · February 2026
GYRO Latest News
No recent news available for GYRO.
GYRO Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for GYRO.
Price Targets
Wall Street price target analysis for GYRO.
GYRO MoonshotScore
What does this score mean?
The MoonshotScore rates GYRO's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Gary Jay Fitlin
CEO
Gary Jay Fitlin serves as the CEO of Gyrodyne, LLC, overseeing the company's strategic direction and day-to-day operations. His background includes extensive experience in real estate management and investment. Prior to joining Gyrodyne, Fitlin held leadership positions at various real estate firms, where he was responsible for property acquisitions, leasing, and development. He holds a degree in Business Administration from a leading university and has completed advanced training in real estate finance and management.
Track Record: Under Gary Jay Fitlin's leadership, Gyrodyne, LLC has expanded its presence on the East Coast and solidified its position as a leading provider of medical office space. He has successfully guided the company through various economic cycles and implemented strategic initiatives to enhance property values and tenant satisfaction. Fitlin's focus on service and innovation has contributed to Gyrodyne's long-term success.
Gyrodyne, LLC Real Estate Stock: Key Questions Answered
What does Gyrodyne, LLC do?
Gyrodyne, LLC is a real estate company that specializes in owning, leasing, and managing commercial properties, with a particular focus on medical office buildings. The company distinguishes itself through a service-oriented approach to property management, fostering strong tenant relationships and stable occupancy rates. Gyrodyne has expanded from a regional Long Island player to a diversified East Coast presence, catering to the specific needs of healthcare providers and other commercial tenants. Their business model centers around generating revenue through rental income and increasing property value through strategic improvements.
What do analysts say about GYRO stock?
As a privately held company, Gyrodyne, LLC is not typically covered by traditional stock analysts. However, considering its focus on medical office properties and its strategic East Coast presence, key valuation metrics would include capitalization rates (cap rates), occupancy rates, and net operating income (NOI). Growth considerations would focus on the company's ability to expand its portfolio, maintain high occupancy rates, and adapt to changing healthcare regulations. The company's lean operational structure and service-oriented approach could contribute to long-term value creation.
What are the main risks for GYRO?
Gyrodyne, LLC faces several key risks inherent to the real estate industry. Fluctuations in interest rates could impact property values and increase financing costs. Economic downturns could reduce demand for commercial real estate, leading to lower occupancy rates and rental income. Increased competition from larger REITs with greater resources could put pressure on Gyrodyne's market share. Changes in healthcare regulations could affect tenant occupancy and the demand for medical office space. Effective risk management strategies are crucial for Gyrodyne to mitigate these potential challenges.
What are the key factors to evaluate for GYRO?
Gyrodyne, LLC (GYRO) holds an AI score of 45/100 (low). Not financial advice.
How frequently does GYRO data refresh on this page?
GYRO prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven GYRO's recent stock price performance?
Gyrodyne, LLC (GYRO) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Service-oriented approach to property management. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider GYRO overvalued or undervalued right now?
Valuing Gyrodyne, LLC (GYRO) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying GYRO?
Before investing in Gyrodyne, LLC (GYRO), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available sources and may be subject to change.
- Financial data is limited due to the company's private status.